Manon Roxanne Schipper1, Naomi Vlegels2,3, Sabine Voigt1,4, Thijs W. van Harten1, Alberto de Luca2,5, Ingeborg Rasing4, Geert Jan Biessels2, Matthias J.P. van Osch1, Marianne A.A. van Walderveen1, and Marieke J.H. Wermer4
1Radiology, Leiden University Medical Center, Leiden, Netherlands, 2Neurology and Neurosurgery, University Medical Center Utrecht, Utrecht, Netherlands, 3LMU Klinikum, München, Germany, 4Neurology, Leiden University Medical Center, Leiden, Netherlands, 5Image Sciences Institute, University Medical Center Utrecht, Utrecht, Netherlands
Synopsis
Keywords: White Matter, Diffusion Tensor Imaging, PSMD
Vascular
reactivity is an early marker of Cerebral Amyloid Angiopathy (CAA), but its
relation to structural brain damage remains unclear. We aimed to study this
relationship in Dutch-type CAA (D-CAA; genetic form of CAA): vascular
reactivity and microstructural white matter integrity were studied through
visually stimulated fMRI and ‘Peak width Skeletonized Mean Diffusivity (PSMD)’.
Reduced BOLD amplitude, delayed time to peak, and delayed time to baseline were
significantly related to a higher PSMD (β=-1.15e-02, β =1.08e-05, β=8.64e-06, respectively). These results indicate
that vascular reactivity and microstructural white matter integrity may
deteriorate hand-in-hand in D-CAA.
Introduction
Cerebral Amyloid
Angiopathy (CAA) is one the leading etiologies of intracerebral hemorrhages in
the elderly1. Dutch-type CAA (D-CAA) is an autosomal dominant
hereditary form of CAA that is caused by a genetic mutation on the amyloid
precursor protein (APP) gene2. D-CAA can be confirmed through
genetic testing, which enables studying the early presymptomatic phase of the
disease, together with the symptomatic phase. In general, D-CAA is considered as
a model for sporadic CAA. Vascular reactivity is an early marker of CAA3,4,
but its relation to structural brain damage remains unclear. The aim of this
study was to investigate the relationship between reactivity alterations and microstructural
white matter integrity measured by the diffusion measure ‘Peak width
Skeletonized Mean Diffusivity (PSMD)’ in (pre-)symptomatic D-CAA mutation
carriers. Methods
Diffusion
tensor imaging (DTI; TE/TR 76/8194ms, FA 90°, 48 slices, FOV 220x220x120mm, voxel size
1.72x1.72x2.5mm, 45 gradient directions with b-value 1200s/mm2, 1 baseline
image with b-value 0s/mm2, scan duration ~6:30 min) and reactivity measurements by visually
stimulated fMRI (TE/TR 38/1500, FA 78°, 18 slices, 0.5mm interslice gap, FOV
210x177x59mm, voxel size 2.5x2.5x2.81mm, 224 dynamics, scan duration ~5:40 min) in the V1 of the visual cortex were
acquired at 3Tesla in 25 D-CAA mutation carriers (mean 45±13.3yrs, range 28-71yrs, 64% women; 15 pre-symptomatic).
The visual stimulus paradigm of the fMRI scan consisted of 7 blocks of an 8Hz
flashing radial black and white checkerboard pattern, for 20s, followed by a
grey screen for 28s3. Based on a trapezoid fit to the Blood-Oxygen-Level-Dependent
(BOLD) response, we calculated normalized amplitude, time to peak (TTP), and
time to baseline (TTB) of the BOLD response3. When the amplitude was
too low, timing parameters TTP and TTB were not calculated. Based on the DTI, robust
and fully automated PSMD was calculated5 (Figure 2). Associations
between the vascular reactivity measures (amplitude, TTP, and TTB) and PSMD were
tested using linear regression analyses (Figure 3B-D).Results
BOLD
amplitude was decreased and PSMD, TTP, and TTB were increased in symptomatic versus
presymptomatic D-CAA mutation carriers (Figure 3). Amplitude, TTP, and TTB are significantly
related to PSMD values (β=-1.15e-02,
p<.001; β =1.08e-05,
p=.009; β=8.64e-06,
p=.004, respectively). When looking only at the presymptomatic D-CAA mutation
carriers, these relations are no longer statistically significant. Discussion and conclusion
Reduced
vascular reactivity as depicted by reduced BOLD amplitude, and delayed TTP and
TTB is related to microstructural white matter brain damage assessed through
increased PSMD. This relationship indicates that vascular and microstructural
white matter integrity loss go hand-in-hand in D-CAA. When looking only at the
presymptomatic phase, the found effects are no longer statistically significant.
Thus, the effects give insight into the disease progression and how vascular
reactivity and microstructural white matter integrity progress from the presymptomatic
to the symptomatic phase. With this cross-sectional study no causal relation
can be proven. Acknowledgements
M.R. Schipper was funded by the
TRACK D-CAA consortium consisting
of Biogen,
Alnylam,
and
researchers
from
Leiden, Boston, and
Perth.
N.
Vlegels was funded
by
the
Heart
Brain Connection Consortium.
References
1.
Aguilar,
M.I. and T.G. Brott, Update in
Intracerebral Hemorrhage. The Neurohospitalist, 2011. 1(3): p. 148-159.
2. Bakker, E., et al., DNA diagnosis for hereditary cerebral
hemorrhage with amyloidosis (Dutch type). Am J Hum Genet, 1991. 49(3): p. 518-21.
3.
Dumas, A., Dierksen, G.A., Edip Gurol, M., Ann
Neurol. 2012, 72(1): p. 76-81.
4.
Opstal, A.M. van, Rooden, S. van, Harten, T.W.
van, Lancet Neurol. 2017, 16(2): p. 115-122.
5.
Baykara, E., Gesierich, B., Adam, R. Ann Neurol.
2016, 80(4): p. 581-592.